Wearable guides
Oura Ring: Finger PPG Sensor and Accuracy
Oura Ring 4 uses an 18-path PPG system: green and infrared LEDs alternate for heart rate and HRV, and red plus infrared LEDs estimate blood oxygen during sleep. Its finger placement can give a strong resting signal, and ECG-referenced studies report close agreement for nightly average heart rate and HRV.
Oura places its optical sensors on the palm side of the finger. Oura Ring 4 uses Smart Sensing to choose among 18 signal paths: green and infrared LEDs alternate for 24/7 heart rate and HRV, red and infrared LEDs measure blood oxygen during sleep, and a digital temperature sensor tracks skin temperature trends (Oura: Smart Sensing).
ECG-referenced studies report close agreement for nightly averages. In 49 adults aged 15–72, nightly average heart rate and HRV from the ring agreed with ECG at r² = 0.996 and 0.980, with mean biases of −0.63 bpm and −1.2 ms; agreement across 5-minute segments was lower (r² 0.869 for heart rate, 0.765 for HRV). The authors worked for Oura (Kinnunen et al., 2020). An independent home study of 35 adults against a Shimmer3 ECG found low mean biases, and per-night averages agreed better than 5-minute segments (Cao et al., 2022). At rest, Oura RMSSD had a mean absolute percent error of 6.84% against ECG (Stone et al., 2021).
Sleep staging results depend on the study. In Oura's own analysis of 440 nights from 106 people, a model using accelerometer, autonomic and circadian features reached 79% accuracy for four stages and 96% for sleep versus wake (Altini & Kinnunen, 2021). In an independent laboratory study of six devices, Oura Ring Gen 2 matched polysomnography on 61% of epochs for sleep stage plus wake (Miller et al., 2022).
Sourced figures
Every number in this guide comes from the source linked beside it. Each study result applies to that study's devices, participants and protocol only.
Nightly average heart rate and HRV vs ECG in 49 adults: r² 0.996 and 0.980; mean bias −0.63 bpm and −1.2 ms (Oura-affiliated authors).
Kinnunen et al. (2020), Physiological Measurement · Oura Ring research record
Independent home study of 35 adults vs Shimmer3 ECG: low mean biases for nocturnal heart rate and HRV; per-night averages agreed better than 5-minute segments.
Cao et al. (2022), Journal of Medical Internet Research · Oura Ring research record
Resting RMSSD vs ECG: mean absolute percent error 6.84% (CCC 0.91).
Stone et al. (2021), Frontiers in Sports and Active Living · Oura Ring research record
Four-stage sleep classification vs polysomnography: 79% accuracy; sleep vs wake 96% (440 nights, 106 people; Oura-affiliated authors).
Altini & Kinnunen (2021), Sensors · Oura Ring research record
Oura Ring Gen 2 vs polysomnography: 61% epoch agreement for sleep stage + wake (κ 0.43); 89% for sleep vs wake (κ 0.51).
Miller, Sargent & Roach (2022), Sensors · Oura Ring Gen2 research record
What published studies show
Results quoted from 16 published validation studies, each against a clinical reference. A result applies to the model and protocol tested, not to every model the brand sells. From the wearable accuracy database (v1.0.0).
Heart rate at rest1 study
| Device tested | Result | Reference | Sample | Study |
|---|---|---|---|---|
| Oura Ring (Gen2) | r = 0.90Pearson correlation | Actiheart (ECG + accelerometer) | n = 21, Free-living, up to 7 days | Henriksen et al. (2022)Independent |
| Oura Ring (Gen2) | 3%Mean absolute percentage error | Actiheart (ECG + accelerometer) | n = 21, Free-living, up to 7 days | Henriksen et al. (2022)Independent |
- Oura Ring (Gen2)r = 0.90
Pearson correlation · vs Actiheart (ECG + accelerometer) · n = 21, Free-living, up to 7 days
Henriksen et al. (2022) Independent
Mean absolute percentage error · vs Actiheart (ECG + accelerometer) · n = 21, Free-living, up to 7 days
Henriksen et al. (2022) Independent
Heart rate during exercise1 study
| Device tested | Result | Reference | Sample | Study |
|---|---|---|---|---|
| Oura Ring Gen3mixed rest/stress/walking | 9–14 bpm (group range)Mean absolute error | ECG chest strap (Zephyr BioHarness / | n = 45, Rest, cognitive stress, steady and intermittent walking in neutral/ | Gielen et al. (2026)Funding not reported |
- Oura Ring Gen39–14 bpm (group range)
Mean absolute error, mixed rest/stress/walking · vs ECG chest strap (Zephyr BioHarness / Faros) · n = 45, Rest, cognitive stress, steady and intermittent walking in neutral/hot/cold chambers
Gielen et al. (2026) Funding not reported
Overnight heart rate3 studies
| Device tested | Result | Reference | Sample | Study |
|---|---|---|---|---|
| Oura Ring Gen3 | 1.67%Mean absolute percentage error | ECG | n = 13, Home, during sleep, 536 nights | Dial et al. (2025)Independent |
| Oura Ring Gen3 | 0.97Lin's concordance correlation | ECG | n = 13, Home, during sleep, 536 nights | Dial et al. (2025)Independent |
| Oura Ring 4 | 1.94%Mean absolute percentage error | ECG | n = 13, Home, during sleep, 536 nights | Dial et al. (2025)Independent |
| Oura Ring 4 | 0.98Lin's concordance correlation | ECG | n = 13, Home, during sleep, 536 nights | Dial et al. (2025)Independent |
| Oura Ring (Gen1/2) | −0.63 bpm (r² 0.996)Mean bias (signed) | ECG | n = 49, Nocturnal | Kinnunen et al. (2020)Maker funded |
| Oura Ring Gen2 | ICC 0.85Intraclass correlation | ECG | n = 53, Overnight, sleep laboratory | Miller et al. (2022)Other maker funded |
- Oura Ring Gen31.67%
Mean absolute percentage error · vs ECG · n = 13, Home, during sleep, 536 nights
Dial et al. (2025) Independent
- Oura Ring Gen30.97
Lin's concordance correlation · vs ECG · n = 13, Home, during sleep, 536 nights
Dial et al. (2025) Independent
- Oura Ring 41.94%
Mean absolute percentage error · vs ECG · n = 13, Home, during sleep, 536 nights
Dial et al. (2025) Independent
- Oura Ring 40.98
Lin's concordance correlation · vs ECG · n = 13, Home, during sleep, 536 nights
Dial et al. (2025) Independent
- Oura Ring (Gen1/2)−0.63 bpm (r² 0.996)
Mean bias (signed) · vs ECG · n = 49, Nocturnal
Kinnunen et al. (2020) Maker funded
- Oura Ring Gen2ICC 0.85
Intraclass correlation · vs ECG · n = 53, Overnight, sleep laboratory
Miller et al. (2022) Other maker funded
1 more result in the database. Heart rate accuracy across devices →
HRV (RMSSD)4 studies
| Device tested | Result | Reference | Sample | Study |
|---|---|---|---|---|
| Oura Ring 4 | 5.96%Mean absolute percentage error | ECG | n = 13, Home, during sleep, 536 nights | Dial et al. (2025)Independent |
| Oura Ring 4 | 0.99Lin's concordance correlation | ECG | n = 13, Home, during sleep, 536 nights | Dial et al. (2025)Independent |
| Oura Ring Gen3 | 7.15%Mean absolute percentage error | ECG | n = 13, Home, during sleep, 536 nights | Dial et al. (2025)Independent |
| Oura Ring Gen3 | 0.97Lin's concordance correlation | ECG | n = 13, Home, during sleep, 536 nights | Dial et al. (2025)Independent |
| Oura Ring (Gen1/2) | −1.2 ms (r² 0.980)Mean bias (signed) | ECG | n = 49, Nocturnal | Kinnunen et al. (2020)Maker funded |
| Oura Ring | 6.84%Mean absolute percentage error | ECG | n = 5, Resting state | Stone et al. (2021)Independent |
- Oura Ring 45.96%
Mean absolute percentage error · vs ECG · n = 13, Home, during sleep, 536 nights
Dial et al. (2025) Independent
- Oura Ring 40.99
Lin's concordance correlation · vs ECG · n = 13, Home, during sleep, 536 nights
Dial et al. (2025) Independent
- Oura Ring Gen37.15%
Mean absolute percentage error · vs ECG · n = 13, Home, during sleep, 536 nights
Dial et al. (2025) Independent
- Oura Ring Gen30.97
Lin's concordance correlation · vs ECG · n = 13, Home, during sleep, 536 nights
Dial et al. (2025) Independent
- Oura Ring (Gen1/2)−1.2 ms (r² 0.980)
Mean bias (signed) · vs ECG · n = 49, Nocturnal
Kinnunen et al. (2020) Maker funded
- Oura Ring6.84%
Mean absolute percentage error · vs ECG · n = 5, Resting state
Stone et al. (2021) Independent
2 more results in the database. HRV accuracy across devices →
Sleep stages (4-stage)6 studies
| Device tested | Result | Reference | Sample | Study |
|---|---|---|---|---|
| Oura Ring Gen3 | 76.0–79.5% (range across stages)Sensitivity | Polysomnography (PSG) | n = 35, Inpatient, 1 night | Robbins et al. (2024)Maker funded |
| Oura Ring Gen3 | Not different from PSG for wake, light, deep or REMStudy finding (no single number) | Polysomnography (PSG) | n = 35, Inpatient, 1 night | Robbins et al. (2024)Maker funded |
| Oura Ring Gen3 (OSSA 2.0) | 75.5% (light) to 90.6% (REM), per-stageEpoch-by-epoch agreement | Polysomnography (PSG) | n = 96, Home ambulatory PSG, up to 3 nights | Svensson et al. (2024)Maker funded |
| Oura Ring | 53.18%Epoch-by-epoch agreement | Polysomnography (PSG) | University sleep laboratory, clinical patients | Herberger et al. (2025)Independent |
| Oura Ring Gen2 | 61%Epoch-by-epoch agreement | Polysomnography (PSG) | n = 53, Sleep laboratory, 1 night, 9 h in bed, all devices worn together | Miller et al. (2022)Other maker funded |
| Oura Ring Gen2 | κ = 0.43Cohen's kappa | Polysomnography (PSG) | n = 53, Sleep laboratory, 1 night, 9 h in bed, all devices worn together | Miller et al. (2022)Other maker funded |
- Oura Ring Gen376.0–79.5% (range across stages)
Sensitivity · vs Polysomnography (PSG) · n = 35, Inpatient, 1 night
Robbins et al. (2024) Maker funded
- Oura Ring Gen3Not different from PSG for wake, light, deep or REM
Study finding (no single number) · vs Polysomnography (PSG) · n = 35, Inpatient, 1 night
Robbins et al. (2024) Maker funded
- Oura Ring Gen3 (OSSA 2.0)75.5% (light) to 90.6% (REM), per-stage
Epoch-by-epoch agreement · vs Polysomnography (PSG) · n = 96, Home ambulatory PSG, up to 3 nights
Svensson et al. (2024) Maker funded
- Oura Ring53.18%
Epoch-by-epoch agreement · vs Polysomnography (PSG) · University sleep laboratory, clinical patients
Herberger et al. (2025) Independent
Epoch-by-epoch agreement · vs Polysomnography (PSG) · n = 53, Sleep laboratory, 1 night, 9 h in bed, all devices worn together
Miller et al. (2022) Other maker funded
- Oura Ring Gen2κ = 0.43
Cohen's kappa · vs Polysomnography (PSG) · n = 53, Sleep laboratory, 1 night, 9 h in bed, all devices worn together
Miller et al. (2022) Other maker funded
3 more results in the database. Sleep accuracy across devices →
Sleep vs wake (2-stage)7 studies
| Device tested | Result | Reference | Sample | Study |
|---|---|---|---|---|
| Oura Ring Gen3 | ≥ 95%Sensitivity | Polysomnography (PSG) | n = 35, Inpatient, 1 night | Robbins et al. (2024)Maker funded |
| Oura Ring Gen3 (OSSA 2.0) | 91.7–91.8%Epoch-by-epoch agreement | Polysomnography (PSG) | n = 96, Home ambulatory PSG, up to 3 nights | Svensson et al. (2024)Maker funded |
| Oura Ring Gen3 (OSSA 2.0) | 94.4–94.5%Sensitivity | Polysomnography (PSG) | n = 96, Home ambulatory PSG, up to 3 nights | Svensson et al. (2024)Maker funded |
| Oura Ring Gen3 (OSSA 2.0) | 73.0–74.6%Specificity | Polysomnography (PSG) | n = 96, Home ambulatory PSG, up to 3 nights | Svensson et al. (2024)Maker funded |
| Oura Ring (Gen1) | 96%Sensitivity | Polysomnography (PSG) | n = 41, Sleep laboratory, 1 night | de Zambotti et al. (2019)Funding not reported |
| Oura Ring (Gen1) | 48%Specificity | Polysomnography (PSG) | n = 41, Sleep laboratory, 1 night | de Zambotti et al. (2019)Funding not reported |
- Oura Ring Gen3≥ 95%
Sensitivity · vs Polysomnography (PSG) · n = 35, Inpatient, 1 night
Robbins et al. (2024) Maker funded
- Oura Ring Gen3 (OSSA 2.0)91.7–91.8%
Epoch-by-epoch agreement · vs Polysomnography (PSG) · n = 96, Home ambulatory PSG, up to 3 nights
Svensson et al. (2024) Maker funded
- Oura Ring Gen3 (OSSA 2.0)94.4–94.5%
Sensitivity · vs Polysomnography (PSG) · n = 96, Home ambulatory PSG, up to 3 nights
Svensson et al. (2024) Maker funded
- Oura Ring Gen3 (OSSA 2.0)73.0–74.6%
Specificity · vs Polysomnography (PSG) · n = 96, Home ambulatory PSG, up to 3 nights
Svensson et al. (2024) Maker funded
Sensitivity · vs Polysomnography (PSG) · n = 41, Sleep laboratory, 1 night
de Zambotti et al. (2019) Funding not reported
Specificity · vs Polysomnography (PSG) · n = 41, Sleep laboratory, 1 night
de Zambotti et al. (2019) Funding not reported
5 more results in the database. Sleep accuracy across devices →
Total sleep time4 studies
| Device tested | Result | Reference | Sample | Study |
|---|---|---|---|---|
| Oura Ring | −75.5 min (older adults)Mean bias (signed) | Polysomnography (PSG) | n = 19, 1 night | Searles et al. (2026)Funding not reported |
| Oura Ring (Gen2) | −32.8 to −47.3 minMean bias (signed) | Polysomnography (PSG) | n = 53, Sleep laboratory, multiple nights, 3 sleep-opportunity conditions | Chee et al. (2021)Maker funded |
| Oura Ring | Group-level TST difference < 12 minStudy finding (no single number) | Polysomnography (PSG) | University sleep laboratory, clinical patients | Herberger et al. (2025)Independent |
| Oura Ring (Gen2) | r = 0.86Pearson correlation | Research actigraphy | n = 45, Home, 7 days | Asgari Mehrabadi et al. (2020)Independent |
- Oura Ring−75.5 min (older adults)
Mean bias (signed) · vs Polysomnography (PSG) · n = 19, 1 night
Searles et al. (2026) Funding not reported
- Oura Ring (Gen2)−32.8 to −47.3 min
Mean bias (signed) · vs Polysomnography (PSG) · n = 53, Sleep laboratory, multiple nights, 3 sleep-opportunity conditions
Chee et al. (2021) Maker funded
- Oura RingGroup-level TST difference < 12 min
Study finding (no single number) · vs Polysomnography (PSG) · University sleep laboratory, clinical patients
Herberger et al. (2025) Independent
- Oura Ring (Gen2)r = 0.86
Pearson correlation · vs Research actigraphy · n = 45, Home, 7 days
Asgari Mehrabadi et al. (2020) Independent
Energy expenditure (calories)2 studies
| Device tested | Result | Reference | Sample | Study |
|---|---|---|---|---|
| Oura Ring (Gen2)total energy expenditure | r = 0.70Pearson correlation | Actiheart / | n = 21, Free-living, up to 7 days | Henriksen et al. (2022)Independent |
| Oura Ring (Gen2) | r = 0.93 (lab)Pearson correlation | Indirect calorimetry | Laboratory activities | Kristiansson et al. (2023)Independent |
- Oura Ring (Gen2)r = 0.70
Pearson correlation, total energy expenditure · vs Actiheart / ActiGraph · n = 21, Free-living, up to 7 days
Henriksen et al. (2022) Independent
- Oura Ring (Gen2)r = 0.93 (lab)
Pearson correlation · vs Indirect calorimetry · Laboratory activities
Kristiansson et al. (2023) Independent
Oura Ring: Finger PPG Sensor and Accuracy Comparisons
Whoop vs Oura Ring: Which Tracks Sleep and HRV Better?
WHOOP is a screenless band worn on the wrist or body; Oura is a ring worn on the finger. Two peer-reviewed studies tested both on the same people. Miller et al. (2022; 53 adults, one night with polysomnography and ECG) found WHOOP 3.0 and Oura Gen 2 close for sleep staging (60% vs 61% epoch agreement) and WHOOP closer for overnight HRV (ICC 0.99 vs 0.63); WHOOP supplied its raw data and funds the lab's research. Dial et al. (2025; 13 adults, 536 nights at home against ECG, no competing interests) tested the newer hardware and found the opposite for HRV: overnight RMSSD error was 5.96% for Oura Ring 4 and 7.15% for Oura Gen3 versus 8.17% for WHOOP 4.0. Resting heart rate error was 1.94%, 1.67% and 3.00%.
View Comparison →Oura Ring Gen 3 vs Gen 4: Is the PPG Sensor Upgrade Worth It?
Oura Ring 4 replaced Gen3 in 2024 with what Oura calls Smart Sensing: an 18-path PPG layout using green and infrared light for heart rate and red and infrared for SpO2. Oura quotes up to 7 days of battery for Gen3 and typically 5–8 days for Ring 4. Both are water resistant to 100 m. No independent study has compared Gen3 and Ring 4 accuracy, so this page does not claim one.
View Comparison →Ultrahuman Ring vs Oura Ring: Specs and Published Evidence
Ultrahuman Ring and Oura Ring are both screenless rings that track sleep, heart rate and HRV from the finger. The difference that matters for accuracy is evidence. Oura rings have been tested against polysomnography and ECG in many peer-reviewed studies, several of them independent. We found no peer-reviewed study that tested an Ultrahuman Ring against a clinical reference. The only Ultrahuman validation is a 2026 medRxiv preprint written by Ultrahuman staff on its VO2max estimate, and no study has tested both rings together. So this page does not rank them on accuracy.
View Comparison →Oura Ring vs Apple Watch: Finger PPG vs Wrist PPG Accuracy
Oura is a ring built mainly for sleep and recovery; Apple Watch is a full smartwatch with ECG. Three studies tested both against polysomnography. In Miller 2022 (53 adults), Oura Gen 2 had higher sleep-stage agreement than Apple Watch Series 6 (61% vs 53%) while Apple Watch tracked overnight heart rate more closely (ICC 0.96 vs 0.85); overnight HRV agreement was similar (0.67 vs 0.63). In the independent Lee 2023 study, four-stage kappa was 0.35 for Oura Gen3 and 0.30 for Apple Watch Series 8. An Oura-funded study (Robbins 2024, 35 adults) reported stage sensitivity of 76.0–79.5% for Oura Gen3 and 50.5–86.1% for Apple Watch Series 8.
View Comparison →Research records
Device records collect datasets, papers, and the sourced figures on this page. For accuracy across the brand, read How accurate is Oura Ring?.
Also named in this guide: Shimmer3
Frequently Asked Questions
Why can finger PPG work well at rest?
The palm side of the finger is well perfused and can give a strong optical pulse signal when the ring fits correctly. Accuracy still depends on fit, motion, circulation and the metric being estimated; no universal wrist-versus-finger multiplier applies.
Can Oura Ring detect atrial fibrillation?
Oura Ring is not an ECG and Oura does not offer an FDA-cleared atrial-fibrillation detection feature. Heart-rate and HRV trends from the ring should not be used to diagnose AF; suspected rhythm problems need an ECG and clinical review.
How accurate is Oura Ring for sleep staging?
Oura's own study reported 79% four-stage accuracy against polysomnography (Altini & Kinnunen, 2021). An independent six-device laboratory study found 61% epoch agreement for Oura Ring Gen 2 on sleep stage plus wake, the second highest of the devices tested (Miller et al., 2022).
Sources
- Oura. Smart Sensing: Unparalleled Accuracy and Personalization in Oura Ring 4
- Kinnunen et al. (2020). Feasible assessment of recovery and cardiovascular health: accuracy of nocturnal HR and HRV assessed via ring PPG in comparison to medical grade ECG. Physiological Measurement. doi:10.1088/1361-6579/ab840a
- Cao et al. (2022). Accuracy Assessment of Oura Ring Nocturnal Heart Rate and Heart Rate Variability in Comparison With Electrocardiography in Time and Frequency Domains: Comprehensive Analysis. Journal of Medical Internet Research. doi:10.2196/27487
- Stone et al. (2021). Assessing the Accuracy of Popular Commercial Technologies That Measure Resting Heart Rate and Heart Rate Variability. Frontiers in Sports and Active Living. doi:10.3389/fspor.2021.585870
- Altini & Kinnunen (2021). The Promise of Sleep: A Multi-Sensor Approach for Accurate Sleep Stage Detection Using the Oura Ring. Sensors. doi:10.3390/s21134302
- Miller, Sargent & Roach (2022). A Validation of Six Wearable Devices for Estimating Sleep, Heart Rate and Heart Rate Variability in Healthy Adults. Sensors. doi:10.3390/s22166317